David Melnick (D Melnick)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Multidrug Resistant

Acinetobacter Baumannii

Coronary Artery

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

H Ganesan, Vipul K Gupta, M C Safir, Sujata M Bhavnani, A K Talley, David Melnick, Christopher M Rubino
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial agents and chemotherapy (2023)
Jon Bruss, Troy Lister, Vipul K Gupta, Emily Stone, Lisa Morelli, Yang Lei, David Melnick
Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206. Antimicrobial agents and chemotherapy 65 (10) (2021)
Angela K Talley, Archie Thurston, Grayson Moore, Vipul K Gupta, Myriah Satterfield, Erika Manyak, Suzanne Stokes, Aaron Dane, David Melnick
First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections. Antimicrobial agents and chemotherapy 65 (11) (2021)